Immune Disease Targets Trend 2026

Therapies for autoimmune and inflammatory conditions rely on pinpointing specific immune disease targets—molecules like cytokines or receptors driving abnormal responses. Researchers use these targets to design biologics or small-molecule drugs that block harmful pathways. Patients with rheumatoid arthritis, psoriasis, or multiple sclerosis benefit most, as treatments aim to reduce symptoms and slow disease progression.